Profile data is unavailable for this security.
About the company
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
- Revenue in USD (TTM)252.34m
- Net income in USD-7.71m
- Incorporated1994
- Employees304.00
- LocationLifeMD Inc236 Fifth Avenue, Suite 400NEW YORK 10001United StatesUSA
- Phone+1 (914) 244-1777
- Fax+1 (302) 655-5049
- Websitehttps://lifemd.com/
More ▼
Mergers & acquisitions
| Acquired company | LFMD:NMQ since announced | Transaction value |
|---|---|---|
| Optimal Human Health MD-Key Assets | -48.44% | 1.82m |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pro-Dex Inc | 70.23m | 11.19m | 126.48m | 181.00 | 11.77 | 3.10 | 10.17 | 1.80 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| Fonar Corp | 105.43m | 6.99m | 136.44m | 535.00 | 17.82 | 0.6953 | 9.73 | 1.29 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| Picard Medical Inc | 4.77m | -33.80m | 138.56m | 75.00 | -- | 17.39 | -- | 29.02 | -0.4673 | -0.4673 | 0.066 | 0.1081 | -- | -- | -- | 63,653.33 | -- | -- | -- | -- | -10.03 | -- | -660.85 | -- | 0.9373 | -0.7808 | 0.0134 | -- | -12.93 | -- | -31.86 | -- | -- | -- |
| Cibus Inc | 3.79m | -118.90m | 141.23m | 157.00 | -- | 2.17 | -- | 37.23 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Treace Medical Concepts Inc | 218.88m | -50.11m | 144.00m | 477.00 | -- | 1.61 | -- | 0.6579 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
| LENSAR Inc | 59.14m | -51.52m | 144.29m | 140.00 | -- | -- | -- | 2.44 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 150.85m | 288.00 | 11.10 | 1.03 | 7.46 | 1.84 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| LifeMD Inc | 252.34m | -7.71m | 151.15m | 304.00 | -- | 111.30 | 30.61 | 0.599 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| Inogen Inc | 347.03m | -25.38m | 153.66m | 766.00 | -- | 0.7793 | -- | 0.4428 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 157.00m | 502.00 | 29.51 | 2.83 | 8.28 | 1.11 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 159.14m | 220.00 | -- | 25.09 | -- | 3.32 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 159.73m | 72.00 | -- | -- | -- | 36.31 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 168.87m | 165.00 | -- | 1.02 | -- | 13.73 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 169.82m | 633.00 | 18.33 | 1.47 | 10.45 | 0.871 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 171.53m | 163.00 | -- | 3.87 | -- | 5.62 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| CVRx Inc | 55.97m | -52.02m | 171.68m | 206.00 | -- | 3.57 | -- | 3.07 | -2.02 | -2.02 | 2.18 | 1.83 | 0.4684 | 0.7458 | 6.49 | 271,694.20 | -43.53 | -37.08 | -47.98 | -40.02 | 84.49 | 81.33 | -92.95 | -151.18 | 8.60 | -8.49 | 0.5072 | -- | 30.53 | 52.31 | -45.55 | -- | 66.61 | -- |
Data as of Feb 06 2026. Currency figures normalised to LifeMD Inc's reporting currency: US Dollar USD
24.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 2.51m | 5.22% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.75m | 3.63% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 1.63m | 3.39% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 1.14m | 2.37% |
| Teachers Advisors LLCas of 30 Sep 2025 | 1.01m | 2.11% |
| Geode Capital Management LLCas of 30 Sep 2025 | 948.38k | 1.97% |
| Royce & Associates LPas of 30 Sep 2025 | 814.45k | 1.69% |
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 775.93k | 1.61% |
| UBS Securities LLCas of 31 Dec 2025 | 672.01k | 1.40% |
| Citadel Securities LLCas of 30 Sep 2025 | 518.25k | 1.08% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
